Aethlon Medical宣布与North Immunology达成合并协议,盘前股价飙升87.4%至2.68美元

美股速递
Sep 17

Aethlon Medical Inc股价在盘前交易中暴涨87.4%,报2.68美元。此前,该公司宣布已与North Immunology签署合并协议。这一重磅消息瞬间点燃市场热情,投资者竞相涌入,推动股价大幅攀升。Aethlon Medical的此番动作,标志着其在生物医药领域的战略布局迈出了关键一步。市场分析人士认为,此次合并有望整合双方优势资源,加速创新疗法的研发与商业化进程,前景值得期待。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10